Selecta Biosciences, Inc. Announces Appointment of Jude Samulski, Ph.D. as Gene Therapy Special Advisor

Selecta Biosciences, Inc. announced the appointment of world renowned AAV gene therapy pioneer Jude Samulski, Ph.D., as a special advisor to assist with the development of their gene therapy programs. Dr. Samulski is professor of pharmacology and has been the director of the University of North Carolina Gene Therapy Center for over two decades.